<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2007-4085</journal-id>
<journal-title><![CDATA[Revista mexicana de urología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. mex. urol.]]></abbrev-journal-title>
<issn>2007-4085</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Urología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2007-40852022000500001</article-id>
<article-id pub-id-type="doi">10.48193/revistamexicanadeurologa.v82i5.888</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Urologic research in the COVID-19 Era: Challenges and Opportunities]]></article-title>
<article-title xml:lang="es"><![CDATA[Investigación urológica en la era COVID-19: desafíos y oportunidades]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Autrán-Gómez]]></surname>
<given-names><![CDATA[Ana María]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tobia]]></surname>
<given-names><![CDATA[Ignacio Pablo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sánchez-Salas]]></surname>
<given-names><![CDATA[Rafael]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Paesano]]></surname>
<given-names><![CDATA[Nahuel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez-Salamanca]]></surname>
<given-names><![CDATA[Juan Ignacio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García-Perdomo]]></surname>
<given-names><![CDATA[Herney Andrés]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Torrico De la Reza]]></surname>
<given-names><![CDATA[Marcelo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[Alejandro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Confederación Americana de Urología  ]]></institution>
<addr-line><![CDATA[ Buenos Aires]]></addr-line>
<country>Argentina</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,LYX Instituto de Urología  ]]></institution>
<addr-line><![CDATA[ Madrid]]></addr-line>
<country>Spain</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad del Valle  ]]></institution>
<addr-line><![CDATA[Cali ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>10</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>10</month>
<year>2022</year>
</pub-date>
<volume>82</volume>
<numero>5</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2007-40852022000500001&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2007-40852022000500001&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2007-40852022000500001&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract The Coronavirus (COVID-19) pandemic, typified as such in March 2020 by the World Health Organization (WHO), has exceeded the capacity of health systems to aid victims, and triggered a radical change in medical research, and in the monitoring of the enrollment for clinical trials in urologic fields around the world. Last year, almost 90% of clinical sites closed patient enrollment, while at the same time, researchers around the world initiated almost 1000 COVID-19 clinical trials. This catastrophic pandemic has allowed us to expand our medical knowledge exponentially. The global urological community has created and published an infinity of scientific articles: establishing guideline reactions for diagnosis, treatment, and follow-up of the different urologic conditions across all areas of the field, reporting the experiences at urology services, and putting forward new strategies. The Confederación Americana de Urología (CAU) has promoted international collaborative projects that have led to gaining insight into how the Latin American Urology Services faced the pandemic, including the challenges, strengths, and the areas of opportunity for urologic care. It also allowed us to increase the number and quality of publications. Also, we have created new virtual platforms and international networks to exchange our knowledge. We have as well transformed this social, economic and health crisis brought upon us by COVID-19, into a source of opportunities for the growth and promotion of research in Latin America. Urologic patients, require researchers to work on favoring their goals. A collaborative network, the established and coordinated protocols, the safety of patients and researchers, assertive and constant communication, and effective technology use, are the essential tools to resume institutional investigation under these critical conditions.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen La pandemia del coronavirus (COVID-19), tipificada como tal en marzo de 2020 por la Organización Mundial de la Salud (OMS), ha superado la capacidad de los sistemas de salud para ayudar a las víctimas y ha desencadenado un cambio radical en la investigación médica y en el seguimiento de los registros para ensayos clínicos en campos urológicos de todo el mundo. El año pasado, casi el 90 % de los sitios clínicos cerraron la inscripción de pacientes, mientras que, al mismo tiempo, investigadores de todo el mundo iniciaron casi 1000 ensayos clínicos de COVID-19. Esta pandemia catastrófica nos ha permitido ampliar exponencialmente nuestro conocimiento médico. La comunidad urológica mundial ha creado y publicado una infinidad de artículos científicos: estableciendo pautas de reacción para el diagnóstico, tratamiento y seguimiento de las diferentes condiciones urológicas en todas las áreas del campo, reportando las experiencias en los servicios de urología y proponiendo nuevas estrategias. La Confederación Americana de Urología (CAU) ha impulsado proyectos de colaboración internacional que han permitido conocer cómo los Servicios de Urología de América Latina enfrentaron la pandemia, incluidos los desafíos, las fortalezas y las áreas de oportunidad para la atención urológica. También nos permitió aumentar el número y la calidad de las publicaciones. Además, hemos creado nuevas plataformas virtuales y redes internacionales para intercambiar nuestro conocimiento. También hemos transformado esta crisis social, económica y de salud que nos ha traído el COVID-19, en una fuente de oportunidades para el crecimiento y fomento de la investigación en América Latina. Los pacientes urológicos, requieren que los investigadores trabajen en favor de sus objetivos. Una red colaborativa, los protocolos establecidos y coordinados, la seguridad de pacientes e investigadores, la comunicación asertiva y constante, y el uso efectivo de la tecnología, son las herramientas esenciales para retomar la investigación institucional en estas condiciones críticas.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[COVID-19]]></kwd>
<kwd lng="en"><![CDATA[coronavirus]]></kwd>
<kwd lng="en"><![CDATA[urologic research]]></kwd>
<kwd lng="en"><![CDATA[Confederación Americana de Urología]]></kwd>
<kwd lng="es"><![CDATA[COVD-19]]></kwd>
<kwd lng="es"><![CDATA[coronavirus]]></kwd>
<kwd lng="es"><![CDATA[investigación urológica]]></kwd>
<kwd lng="es"><![CDATA[Confederación Americana de Urología]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<collab>WIRB-Copernicus Group</collab>
<source><![CDATA[COVID-19 Resources and Services from WCG: Resource Center: COVID-19 and Clinical Trial Operations]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Psotka]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Abraham]]></surname>
<given-names><![CDATA[WT]]></given-names>
</name>
<name>
<surname><![CDATA[Fiuzat]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Filippatos]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Lindenfeld]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ahmad]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Conduct of Clinical Trials in the Era of COVID-19]]></article-title>
<source><![CDATA[Journal of the American College of Cardiology]]></source>
<year>2020</year>
<volume>76</volume>
<numero>20</numero>
<issue>20</issue>
<page-range>2368-78</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Teh]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[O&#8217;Connor]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Coles-Black]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lawrentschuk]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical trials in urological oncology: COVID-19 and the potential need for a new perspective]]></article-title>
<source><![CDATA[World J Urol]]></source>
<year>2021</year>
<volume>39</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>3147-9</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<collab>U.S. Department of Health and Human Services Food and Drug Administration</collab>
<source><![CDATA[FDA Guidance on Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency]]></source>
<year>2021</year>
<publisher-name><![CDATA[Food and Drug Administration (FDA or Agency)]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<collab>National Institutes of Health</collab>
<source><![CDATA[Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19]]></source>
<year>2020</year>
<publisher-name><![CDATA[National Institutes of Health]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<collab>European Medicines Agency</collab>
<source><![CDATA[Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic]]></source>
<year>2022</year>
<publisher-loc><![CDATA[United Kingdom ]]></publisher-loc>
<publisher-name><![CDATA[European Medicines Agency]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saini]]></surname>
<given-names><![CDATA[KS]]></given-names>
</name>
<name>
<surname><![CDATA[Heras]]></surname>
<given-names><![CDATA[B de las]]></given-names>
</name>
<name>
<surname><![CDATA[Castro]]></surname>
<given-names><![CDATA[J de]]></given-names>
</name>
<name>
<surname><![CDATA[Venkitaraman]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Poelman]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Srinivasan]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of the COVID-19 pandemic on cancer treatment and research]]></article-title>
<source><![CDATA[The Lancet Haematology]]></source>
<year>2020</year>
<volume>7</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>e432-5</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nabhan]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Choueiri]]></surname>
<given-names><![CDATA[TK]]></given-names>
</name>
<name>
<surname><![CDATA[Mato]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rethinking Clinical Trials Reform During the COVID-19 Pandemic]]></article-title>
<source><![CDATA[JAMA Oncology]]></source>
<year>2020</year>
<volume>6</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1327-9</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Verna]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
<name>
<surname><![CDATA[Serper]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Chu]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Corey]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Fix]]></surname>
<given-names><![CDATA[OK]]></given-names>
</name>
<name>
<surname><![CDATA[Hoyt]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation]]></article-title>
<source><![CDATA[Hepatology]]></source>
<year>2020</year>
<volume>72</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1819-37</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Petkova]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Antman]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Troxel]]></surname>
<given-names><![CDATA[AB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pooling Data From Individual Clinical Trials in the COVID-19 Era]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2020</year>
<volume>324</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>543-5</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<collab>ICH Harmonised Guideline</collab>
<source><![CDATA[Integrated addendum to ICH E6(R1): Guideline for good clinical practice E6(R2)]]></source>
<year>2016</year>
<publisher-name><![CDATA[International council for harmonisation of technical requirements for pharmaceuticals for human use (ICH)]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Felix]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical Research in the Time of COVID-19]]></article-title>
<source><![CDATA[International Journal of Radiation Oncology, Biology, Physics]]></source>
<year>2020</year>
<volume>108</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>489-90</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abraham]]></surname>
<given-names><![CDATA[WT]]></given-names>
</name>
<name>
<surname><![CDATA[Fiuzat]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Psotka]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[O&#8217;Connor]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Heart Failure Collaboratory Statement on Clinical Trials in the Landscape of COVID-19]]></article-title>
<source><![CDATA[JACC Heart Fail]]></source>
<year>2020</year>
<volume>8</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>423-5</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Du]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[How to safely and smoothly resume trials after the COVID-19 outbreak]]></article-title>
<source><![CDATA[J Glob Health]]></source>
<year>2020</year>
<volume>10</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>020310</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="book">
<collab>National Academies of Sciences E</collab>
<source><![CDATA[Integrating Clinical Research into Epidemic Response: The Ebola Experience]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Washington, D.C ]]></publisher-loc>
<publisher-name><![CDATA[The National Academies Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<collab>American Psychological Association</collab>
<source><![CDATA[Conducting research during the COVID-19pandemic]]></source>
<year>2022</year>
<publisher-name><![CDATA[American Psychological Association]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
